Details for New Drug Application (NDA): 011752
✉ Email this page to a colleague
NDA 011752 describes PRELUDIN, which is a drug marketed by Boehringer Ingelheim and is included in two NDAs. Additional details are available on the PRELUDIN profile page.
The generic ingredient in PRELUDIN is phenmetrazine hydrochloride. Additional details are available on the phenmetrazine hydrochloride profile page.
The generic ingredient in PRELUDIN is phenmetrazine hydrochloride. Additional details are available on the phenmetrazine hydrochloride profile page.
Summary for 011752
| Tradename: | PRELUDIN |
| Applicant: | Boehringer Ingelheim |
| Ingredient: | phenmetrazine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011752
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 75MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
